42 reports of this reaction
1.0% of all DIHYDROERGOTAMINE MESYLATE reports
#20 most reported adverse reaction
EXTRAPYRAMIDAL DISORDER is the #20 most commonly reported adverse reaction for DIHYDROERGOTAMINE MESYLATE, manufactured by Impel Pharmaceuticals LLC. There are 42 FDA adverse event reports linking DIHYDROERGOTAMINE MESYLATE to EXTRAPYRAMIDAL DISORDER. This represents approximately 1.0% of all 4,245 adverse event reports for this drug.
Patients taking DIHYDROERGOTAMINE MESYLATE who experience extrapyramidal disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EXTRAPYRAMIDAL DISORDER is a less commonly reported adverse event for DIHYDROERGOTAMINE MESYLATE, but still significant enough to appear in the safety profile.
In addition to extrapyramidal disorder, the following adverse reactions have been reported for DIHYDROERGOTAMINE MESYLATE:
The following drugs have also been linked to extrapyramidal disorder in FDA adverse event reports:
EXTRAPYRAMIDAL DISORDER has been reported as an adverse event in 42 FDA reports for DIHYDROERGOTAMINE MESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EXTRAPYRAMIDAL DISORDER accounts for approximately 1.0% of all adverse event reports for DIHYDROERGOTAMINE MESYLATE, making it a notable side effect.
If you experience extrapyramidal disorder while taking DIHYDROERGOTAMINE MESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.